Core One Labs Inc C.COOL

Listing application for the CSE

[lscfa]

On sedar

[lscfa]

Expected Changes in the Business of the Company   Core One is in the process of selling its operations related to the cultivation of cannabis in the United States. The Company also expects to shift production from THC CannaStripsTM at a highly regulated T&T facility to CBD CannaStripsTM at a less regulated facility. The shift from THC CannaStripsTM to CBD CannaStripsTM will also allow

[lscfa]

With repeating.......

[lscfa]

Total Funds Available As of the most recent month end prior to the date of this Listing Statement, the Company had working capital deficiency of approximately $3,248,875. Pursuant to the letter of intent with High Tower Capital Inc., High Tower Capital Inc. will pay $3,000,000 for the Assets and will assume $57,593 and USD$4,015,885 (combined, approximately $5,285,070) of liabilities related to

[Nickel77]

Iscfa As of this date, I dont beleive HIGH TOWER has bought any assets from COOL.  Most likely doing a lot more due diligence on COOL.. Who knows what mess Brad has left?   

[lscfa]

Applicable now.  

[CancerSlayer]

Yep, finally have WC....a new milestone achieved thanks to new mgmt...& Brad should be wearing orange by now.  Now let's see a patent filing, a successful batch of synthetic psilocybin, psilocybin incorporation into their thin strip technology, & maybe an early stage scale-up...all by year end? : ).  A well-designed & expensive clinical trial investigating the strip

[Tony501]

Cancer. You are bang on!! If Joel can execute like you explain we are set to be a leader in the shroom market long term.